Starting insulin for Type 2 diabetes with insulin glargine added to oral agents versus twice-daily premixed insulin alone

被引:0
|
作者
Janka, HU
Plewe, G
Kliebe-Frisch, C
Schweitzer, MA
Yki-Järvinen, H
机构
[1] Zent Krankenhaus Bremen Nord, Bremen, Germany
[2] Aventis Pharma Deutschland GmbH, Bad Soden, Germany
[3] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
744
引用
收藏
页码:A269 / A270
页数:2
相关论文
共 50 条
  • [1] Starting insulin for type 2 diabetes with insulin glargine added to oral agents vs twice-daily premixed insulin alone
    Janka, H
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    [J]. DIABETES, 2004, 53 : A130 - A130
  • [2] Treatment satisfaction with a basal insulin added to oral agents versus twice-daily premixed insulin alone in patients with type 2 diabetes
    Bradley, C
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Janka, HU
    [J]. DIABETES, 2005, 54 : A304 - A304
  • [3] Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
    Janka, HU
    Kliebe-Frisch, C
    Plewe, G
    Schweitzer, MA
    Riddle, MC
    Yki-Jarvinen, H
    [J]. DIABETES CARE, 2005, 28 (02) : 254 - 259
  • [4] Economics of basal insulin added to oral agents versus twice-daily premixed insulin as initial therapy for type 2 diabetes
    Sclar, DA
    Evans, MA
    White, JR
    Skaer, TL
    Robison, LM
    [J]. DIABETOLOGIA, 2005, 48 : A335 - A335
  • [5] Economics of basal insulin added to oral agents versus twice-daily premixed insulin as initial therapy for type 2 diabetes
    Sclar, DA
    Evans, MA
    White, JR
    Skaer, TL
    Robison, LM
    [J]. DIABETES, 2005, 54 : A607 - A607
  • [6] Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride
    Kann, P. H.
    Wascher, T.
    Zackova, V.
    Moeller, J.
    Medding, J.
    Szocs, A.
    Mokan, M.
    Mrevlje, F.
    Regulski, M.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) : 527 - 532
  • [7] Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
    Eledrisi, Mohsen
    Suleiman, Noor Nabeel
    Salameh, Obada
    Hamad, Mohammad Khair
    Rabadi, Omar
    Mohamed, Ahmed
    Al Adawi, Rana
    Salam, Abdul
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 15 : 35 - 36
  • [8] Comparison of efficacy between twice-daily premixed insulin and once-daily insulin glargine combined with oral hypoglycemic drugs
    Kutoh, E
    Wajs, J
    [J]. DIABETES, 2005, 54 : A494 - A494
  • [9] Daily haemodialysis and twice-daily insulin glargine to battle unstable Type 1 diabetes
    Lee, A.
    Joseph, E.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [10] Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in elderly patients with type 2 diabetes
    Janka, HU
    Plewe, G
    Busch, K
    Kliebe-Frisch, C
    Peiker, J
    Schweitzer, MA
    [J]. DIABETES, 2005, 54 : A144 - A144